查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1971000

獸用鎮靜劑市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、給藥途徑、地區和競爭格局分類，2021-2031年

Animal Sedative Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Acepromazine, Butorphanol, Detomidine, Romifidine, Xylazine), By Route of Administration (Oral, Parenteral), By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球動物鎮靜劑市場預計將從 2025 年的 1.3204 億美元成長到 2031 年的 1.7344 億美元，複合年成長率為 4.65%。

這些藥物對牲畜和伴侶動物至關重要，有助於放鬆身心、減輕焦慮，並確保它們在運輸和獸醫手術過程中保持靜止。推動成長的主要因素包括外科手術數量的增加以及關於安全操作的動物福利法規的日益嚴格。此外，寵物的人性化趨勢也促使飼主在先進的醫療保健方面投入更多資金。例如，根據美國寵物用品協會 (APPA) 的報告，預計到 2024 年，美國寵物產業的總支出將達到 1,520 億美元，這凸顯了該市場對動物健康領域的巨大經濟貢獻。

市場概覽
預測期 2027-2031
市場規模：2025年 1.3204億美元
市場規模：2031年 1.7344億美元
複合年成長率：2026-2031年 4.65%
成長最快的細分市場 醋丙嗪
最大的市場 北美洲

儘管獸藥市場前景廣闊，但由於其嚴格的監管核准框架，仍面臨許多挑戰。製造商必須投入大量時間和資金來向國際組織證明產品的安全性和有效性，這導致市場進入門檻極高。這種複雜的合規環境常常延緩新配方的上市，並限制了小型動物產品的供應。因此，這些監管障礙在很大程度上限制了市場發展，並阻礙了該領域的創新步伐。

市場促進因素

全球寵物飼養量的不斷成長以及動物擬人化的趨勢，正成為全球動物鎮靜劑市場的主要驅動力。這是因為飼主越來越將寵物視為家庭成員，並要求它們獲得最高標準的獸醫護理。這種文化轉變推動了對鎮靜劑的需求，以確保患者在影像影像檢查、牙科治療和複雜外科手術過程中的舒適和安全。市場潛力巨大，歐洲動物及動物保健聯合會（FEDIAF）2025年6月發布的《事實與數據》報告證實了這一點，該報告指出，歐洲將有1.39億個家庭至少擁有一隻寵物。這種需求帶來的經濟影響體現在主要產業參與者的成功上。例如，碩騰（Zoetis）在2025年2月的財報中披露，2024會計年度的總收入達到93億美元，顯示全球對動物保健產品的投資龐大。

此外，工業化畜牧養殖和畜牧生產的擴張是市場成長的主要驅動力，使得鎮靜劑在畜群管理、運輸和小型手術中不可或缺。隨著肉類畜價值的提升，生產者優先考慮符合動物福利標準的鎮靜方法，以防止因受傷和壓力導致的體重下降。該行業的規模龐大，美國農業部於2025年4月發布的《2024年家禽生產和價值概要》便印證了這一點，該概要估計2024年美國肉雞產量將達到454億美元。因此，農業生產集約化的不斷提高導致鎮靜劑製劑的採購量增加，以維持生產力、保障工人安全並符合國際動物福利標準。

市場挑戰

獸藥嚴格的監管核准流程嚴重阻礙了全球動物鎮靜劑市場的發展。生產商必須克服高昂的資金投入和漫長的核准流程，才能獲得國際監管機構要求的安全性和有效性數據。對於牲畜鎮靜劑而言，這項挑戰尤其嚴峻，因為牲畜鎮靜劑需要嚴格的停藥期以確保食品安全；而伴侶動物產品則需要進行廣泛的物種特異性耐受性測試。這些嚴格的合規標準延緩了新化合物的上市，並抑制了對少數物種治療藥物的投資，因為這些藥物的潛在收益往往不足以彌補巨額的監管成本。

如此嚴格的監管環境不僅扼殺了創新，也縮小了可供選擇的產品範圍。隨著合規成本的上升，製造商可能被迫將現有低利潤配方撤出市場，從而限制獸醫可用的治療方案。這些法規的影響在近期的行業統計數據中顯而易見。根據加拿大動物健康研究所2024年的報告，過去八年中，市場上獲得許可的動物用藥品數量下降了42.3%，主要原因是監管成本上升和行政壓力增加。這些數據表明，監管負擔正在透過減少基本藥物的多樣性和可及性，直接阻礙市場擴張。

市場趨勢

隨著寵物飼主尋求藥物療法來應對煙火、雷暴和旅行等非手術壓力因素，市場格局正在重塑，對噪音恐懼和情境性焦慮治療的需求日益成長。這一趨勢正將焦點從傳統鎮靜劑轉向特定配方，例如起效迅速且作用可逆的口腔黏膜凝膠，以便在家中進行焦慮管理。 Orion Co., Ltd. 於 2024 年 10 月發布的《2024 年中期報告（1 月至 9 月）》充分體現了這一細分市場的商業性實力。報告顯示，包括噪音焦慮治療藥物在內的獸用鎮靜劑在 2024 年前九個月的銷售額達到 2,580 萬歐元。這表明，獸醫學界在關注寵物身心健康的同時，也越來越重視其行為健康。

此外，無恐懼獸醫標準的普及正在改變臨床工作流程，強制要求在就診前使用預檢藥物（PVP）來減輕患者的壓力。這個通訊協定的改變導致常規檢查和小型手術中抗焦慮藥物和鎮靜劑的處方量增加，從而創造了一條獨立於手術麻醉的穩定收入來源。這些低壓力方法的快速普及在產業趨勢中顯而易見，美國動物醫院協會（AAHA）宣布，截至2024年3月，已有超過32萬名獸醫專業人員和寵物專科醫生加入了無恐懼計畫。這項廣泛的認證進一步增加了對口服鎮靜劑的需求，這些藥物可以提高遵守用藥，並確保與獸醫人員的安全互動。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：獸用鎮靜劑全球市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依類型（醋丙嗪、Butorphanol、地托咪定、羅米非定、賽拉嗪）
    • 給藥途徑（口服、注射）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美獸用鎮靜劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲獸用鎮靜劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區動物鎮靜劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲動物鎮靜劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲動物鎮靜劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球動物鎮靜劑市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Zoetis Inc
  • Boehringer Ingelheim International GmbH
  • Merck & Co., Inc.
  • Elanco Animal Health Inc
  • Virbac SA
  • Dechra Pharmaceuticals Limited
  • Orion Corporation
  • Vetoquinol SA
  • Bimeda, Inc.
  • Chanelle Pharma Group

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 19183

The Global Animal Sedative Market is projected to expand from USD 132.04 Million in 2025 to USD 173.44 Million by 2031, registering a CAGR of 4.65%. These pharmacological agents are essential for livestock and companion animals, serving to induce relaxation, reduce anxiety, and ensure immobilization during transport or veterinary interventions. Growth is primarily driven by an increasing number of surgical procedures and a stricter adherence to animal welfare regulations regarding safe handling. Additionally, the trend of pet humanization encourages owners to spend more on advanced medical care; for instance, the American Pet Products Association reported that total U.S. pet industry expenditures hit $152 billion in 2024, highlighting the significant financial dedication to animal health that underpins this market.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 132.04 MIllion
Market Size 2031USD 173.44 MIllion
CAGR 2026-20314.65%
Fastest Growing SegmentAcepromazine
Largest MarketNorth America

Despite these growth prospects, the market faces substantial obstacles due to the stringent regulatory approval frameworks for veterinary pharmaceuticals. Manufacturers must invest considerable time and capital to prove safety and efficacy to international bodies, creating high entry barriers. This complex compliance environment frequently postpones the launch of new formulations and restricts the availability of products for minor species. Consequently, these regulatory hurdles limit broader market development and hinder the pace of innovation within the sector.

Market Driver

The rising trend of global pet ownership and the humanization of animals act as major catalysts for the Global Animal Sedative Market, as owners increasingly treat pets as family members requiring top-tier veterinary attention. This cultural evolution spurs demand for sedatives needed during diagnostic imaging, dental work, and complex surgeries to ensure patient comfort and safety. The market potential is vast, evidenced by the FEDIAF 'Facts & Figures' report from June 2025, which noted that 139 million European households own at least one pet. The economic impact of this bond is reflected in the success of key industry players; for example, Zoetis reported a total revenue of $9.3 billion for 2024 in its February 2025 results, signaling massive global investment in animal wellness products.

Furthermore, the expansion of industrial animal agriculture and livestock production drives significant market growth, requiring sedatives for herd management, transportation, and minor surgeries. As the value of food animals increases, producers are prioritizing welfare-compliant sedation to prevent injury and stress-related weight loss. The scale of this sector is immense, as highlighted by the USDA's 'Poultry - Production and Value 2024 Summary' released in April 2025, which valued U.S. broiler production at $45.4 billion in 2024. Accordingly, the intensification of farming operations leads to higher procurement of sedative formulations to maintain productivity, ensure handler safety, and satisfy international welfare standards.

Market Challenge

Stringent regulatory approval processes for veterinary pharmaceuticals represent a major hurdle to the growth of the global animal sedative market. Manufacturers must navigate high capital costs and lengthy timelines to produce the safety and efficacy data required by international regulatory bodies. This challenge is particularly acute for livestock sedatives, which demand precise withdrawal periods to guarantee food safety, while companion animal products require extensive testing for species-specific tolerability. These rigorous compliance standards often delay the release of new compounds and discourage investment in treatments for minor species, where the potential returns often fail to cover the steep regulatory expenses.

This environment of intense scrutiny not only stifles innovation but also contracts the range of available products. As the cost of compliance escalates, manufacturers may withdraw existing low-margin formulations, thereby limiting the therapeutic options accessible to veterinarians. The impact of these restrictions is clear in recent industry statistics; the Canadian Animal Health Institute reported in 2024 that the number of licensed veterinary drugs on the market had dropped by 42.3% over the previous eight years, a decline largely driven by rising regulatory fees and administrative pressures. Such data demonstrates how regulatory burdens directly impede market expansion by reducing the diversity and availability of essential pharmaceutical products.

Market Trends

The market is being reshaped by the growing demand for therapeutics addressing noise aversion and situational anxiety, as pet owners seek pharmacological remedies for non-surgical stressors like fireworks, thunderstorms, and travel. This trend is shifting focus from traditional immobilization agents toward specific formulations, such as oromucosal gels, which provide rapid onset and reversibility for managing anxiety at home. The commercial strength of this niche is highlighted by Orion Corporation's 'Interim Report 1-9/2024' from October 2024, which showed sales of animal sedatives, including noise anxiety treatments, reaching EUR 25.8 million for the first nine months. This indicates a growing emphasis on behavioral wellness alongside physical health in veterinary care.

Additionally, the mainstream adoption of Fear-Free veterinary practice standards is transforming clinical workflows by necessitating the use of Pre-Visit Pharmaceuticals (PVPs) to reduce patient stress prior to appointments. This protocol shift is driving prescriptions for anxiolytics and sedatives for routine exams and minor procedures, generating a consistent revenue stream separate from surgical anesthesia. The swift uptake of these low-stress techniques is evident in the industry landscape; the American Animal Hospital Association noted in March 2024 that over 320,000 veterinary and pet professionals have registered for Fear Free programs. This widespread certification fuels the need for oral sedative options that improve compliance and ensure safer interactions for veterinary staff.

Key Market Players

  • Zoetis Inc
  • Boehringer Ingelheim International GmbH
  • Merck & Co., Inc.
  • Elanco Animal Health Inc
  • Virbac S.A.
  • Dechra Pharmaceuticals Limited
  • Orion Corporation
  • Vetoquinol SA
  • Bimeda, Inc.
  • Chanelle Pharma Group

Report Scope

In this report, the Global Animal Sedative Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Animal Sedative Market, By Type

  • Acepromazine
  • Butorphanol
  • Detomidine
  • Romifidine
  • Xylazine

Animal Sedative Market, By Route of Administration

  • Oral
  • Parenteral

Animal Sedative Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Animal Sedative Market.

Available Customizations:

Global Animal Sedative Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Animal Sedative Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Acepromazine, Butorphanol, Detomidine, Romifidine, Xylazine)
    • 5.2.2. By Route of Administration (Oral, Parenteral)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Animal Sedative Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Route of Administration
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Animal Sedative Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Route of Administration
    • 6.3.2. Canada Animal Sedative Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Route of Administration
    • 6.3.3. Mexico Animal Sedative Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Route of Administration

7. Europe Animal Sedative Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Route of Administration
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Animal Sedative Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Route of Administration
    • 7.3.2. France Animal Sedative Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Route of Administration
    • 7.3.3. United Kingdom Animal Sedative Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Route of Administration
    • 7.3.4. Italy Animal Sedative Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Route of Administration
    • 7.3.5. Spain Animal Sedative Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Route of Administration

8. Asia Pacific Animal Sedative Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Route of Administration
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Animal Sedative Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Route of Administration
    • 8.3.2. India Animal Sedative Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Route of Administration
    • 8.3.3. Japan Animal Sedative Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Route of Administration
    • 8.3.4. South Korea Animal Sedative Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Route of Administration
    • 8.3.5. Australia Animal Sedative Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Route of Administration

9. Middle East & Africa Animal Sedative Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Route of Administration
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Animal Sedative Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Route of Administration
    • 9.3.2. UAE Animal Sedative Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Route of Administration
    • 9.3.3. South Africa Animal Sedative Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Route of Administration

10. South America Animal Sedative Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Route of Administration
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Animal Sedative Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Route of Administration
    • 10.3.2. Colombia Animal Sedative Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Route of Administration
    • 10.3.3. Argentina Animal Sedative Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Route of Administration

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Animal Sedative Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Zoetis Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Boehringer Ingelheim International GmbH
  • 15.3. Merck & Co., Inc.
  • 15.4. Elanco Animal Health Inc
  • 15.5. Virbac S.A.
  • 15.6. Dechra Pharmaceuticals Limited
  • 15.7. Orion Corporation
  • 15.8. Vetoquinol SA
  • 15.9. Bimeda, Inc.
  • 15.10. Chanelle Pharma Group

16. Strategic Recommendations

17. About Us & Disclaimer